André Viljoen,logistics manager at Artemis Aerospace, offers some positive advice to help you overcome your fear of flying.
Category: Personal Care & Services
Breakthrough CRISPR Technology Study Published in Nature
The research paper, titled “Cas12a2 elicits abortive infection via RNA-triggered destruction of dsDNA,” discusses the discovery of a new enzymatic capability for CRISPR systems
Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
Agilent’s investment will double capacity to produce active pharmaceutical ingredients used in therapeutics for a broad range of diseases.
Cyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease
Biologic similarities demonstrated between Niemann-Pick Disease Type C and Alzheimer’s disease bolsters rationale for studying Trappsol® Cyclo™ for the treatment of early Alzheimer’s disease.
New Study Reports Broad Applicability of InGeneron’s Regenerative Cell Therapy System Across Patient Groups
New study finds the composition of adipose-derived regenerative cells using InGeneron’s Transpose® RT system does not depend on the subject’s age, sex, body mass index, or ethnicity.
Spero Health Brings Relief for Addiction and Lifesaving Care to Thousands in 2022
Spero Health released a 2022 organizational summary of the impact their outpatient addiction treatment program has had on communities struggling with the drug epidemic.
HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
HeartBeam, Inc. announced today that its patent that enables generation of a synthesized 12-lead ECG by the HeartBeam AIMIGo™ credit card-sized device was issued by the European Patent Office.
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
Cardiovascular Systems, Inc. announced today that Innova Vascular, Inc. (Innova) has submitted a 510(k) Premarket Notification to the U.S. Food and Drug Administration (FDA) for its thrombectomy devices intended to treat peripheral vascular disease.
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company
Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders held today.
